4AJ1 | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH N-(2-(METHYLAMINO)-1,3-BENZOTHIAZOL-6-YL)ACETAMIDE |
4AJ2 | A:160-331; C:160-331; D:160-331; B:160-331 | RAT LDHA IN COMPLEX WITH 5-(2-CHLOROPHENYL)-1H-TETRAZOLE |
4AJ4 | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH 4-((2-ALLYLSULFANYL-1,3-BENZOTHIZOL-6-YL) AMINO)-4-OXO-BUTANOIC ACID |
4AJE | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH 2-(4-BROMOPHENOXY)PROPANEDIOIC ACID |
4AJH | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH N-(2-METHYL-1,3-BENZOTHIAZOL-6-YL)-3-UREIDO-PROPANAMIDE AND 2-(4-BROMOPHENOXY)PROPANEDIOIC ACID |
4AJI | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH 2-((3,4-DIMETHOXYPHENYL)METHYL)) PROPANEDIOIC ACID |
4AJJ | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH 2-((3,4-DIMETHOXYPHENYL)METHYL)) PROPANEDIOIC ACID AND N-(2-METHYL-1,3-BENZOTHIAZOL-6-YL)-3-UREIDO-PROPANAMIDE |
4AJK | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH N-(2-(METHYLAMINO)-1,3-BENZOTHIAZOL-6-YL) ACETAMIDE |
4AJL | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH 3-(ETHYLCARBAMOYLAMINO)-N-(2-METHYL-1,3-BENZOTHIAZOL-6-YL)PROPANAMIDE |
4AJN | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH 2-((4-(2-((3-((2-METHYL-1,3-BENZOTHIAZOL-6-YL)AMINO)-3-OXO-PROPYL)CARBAMOYLAMINO)ETHYL) PHENYL)METHYL)PROPANEDIOIC ACID |
4AJO | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH 2-((4-(4-((3-((2-METHYL-1,3-BENZOTHIAZOL-6YL)AMINO)-3-OXO-PROPYL)AMINO)-4-OXO-BUTYL) PHENYL)METHYL)PROPANEDIOIC ACID |
4AL4 | A:160-331; B:160-331; C:160-331; D:160-331 | RAT LDHA IN COMPLEX WITH 2-((4-(2-((3-((2-METHYL-1,3-BENZOTHIAZOL-6-YL)AMINO)3-OXO-PROPYL)CARBAMOYLAMINO)ETHOXY) PHENYL) METHYLPROPANEDIOIC ACID |